Mometasone Furoate Monohydrate + Orbifloxacin + Posaconazole
89 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
89
Total Reports
5
Deaths Reported
560.0%
Death Rate
Active Ingredients
Mometasone Furoate MonohydrateMometasone Furoate Monohydrate + Orbifloxacin + PosaconazoleOrbifloxacinPosaconazole
Administration Routes
Auricular (Otic)UnknownTopical
Species Affected
Dog 87
Cat 2
Most Affected Breeds
Retriever - Labrador 17
Bulldog - French 5
Terrier - Yorkshire 4
Beagle 3
Pekingese 3
Spaniel - Cocker American 3
Terrier - Bull - American Pit 2
Pug 2
Spaniel - Cocker English 2
Poodle - Standard 2
Most Reported Reactions
Lack of efficacy - NOS 20
Vomiting 19
Emesis 13
Lethargy (see also Central nervous system depression in 'Neurological') 11
Other abnormal test result NOS 11
Ocular discharge 9
Diarrhoea 8
Ear infection NOS 8
Nasal discharge 8
Lethargy (see also Central nervous system depression in Neurological) 8
Anorexia 7
Ataxia 7
Outcome Breakdown
Outcome Unknown
32 (36.0%)
Recovered/Normal
27 (30.3%)
Ongoing
21 (23.6%)
Recovered with Sequela
4 (4.5%)
Euthanized
4 (4.5%)
Died
1 (1.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.